Lancet Capital focuses on early stage, emerging biomedical technologies and opportunities including:

Lancet invests in exceptional researchers, clinicians and entrepreneurs to commercialize innovative technologies in the biomedical field. Lancet is able to offer value-adding human capital in the venture-building process by providing: